首页> European journal of human genetics : EJHG> CHEK2*1100delC homozygosity in the Netherlands--prevalence and risk of breast and lung cancer.

CHEK2*1100delC homozygosity in the Netherlands--prevalence and risk of breast and lung cancer.

导出 OA

翻译打印收藏纠错

第一作者： Petra E A,Huijts

第一单位： Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.

作者： Petra E A,Huijts ^[1] ; Antoinette,Hollestelle ^[2] ; Brunilda,Balliu ^[3] ; Jeanine J,Houwing-Duistermaat ^[3] ; Caro M,Meijers ^[1] ; Jannet C,Blom ^[2] ; Bahar,Ozturk ^[2] ; Elly M M,Krol-Warmerdam ^[4] ; Juul,Wijnen ^[5] ; Els M J J,Berns ^[2] ; John W M,Martens ^[2] ; Caroline,Seynaeve ^[2] ; Lambertus A,Kiemeney ^[6] ; Henricus F,van der Heijden ^[7] ; Rob A E M,Tollenaar ^[4] ; Peter,Devilee ^[1] ; Christi J,van Asperen ^[5]

作者单位： Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. ^[1] Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands. ^[2] Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands. ^[3] Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. ^[4] Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. ^[5] Department of Epidemiology, Biostatistics and HTA, Radboud University Medical Center, Nijmegen, The Netherlands. ^[6] Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, The Netherlands. ^[7]